The Business Journals

NeuroMetrix’s Sensus device for diabetics approved for use during sleep

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Stock in NeuroMetrix Inc. (Nasdaq:NURO) jumped as high as ...
Yahoo Finance

Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego

BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and ...
Seeking Alpha

Sensus Healthcare: Better Outcomes For Painful Procedures

Sensus Healthcare, Inc. is working to recover from a tough Q3, 2022. Preliminary Q4 2022 earnings are reigniting interest in Sensus Healthcare. Sensus Healthcare, Inc. products serve both the clinical ...
Boston Magazine

Pain Relief Device Now Approved For Overnight Use

Waltham-based medical device company NeuroMetrix has created the SENSUS Pain Management System, a non-invasive device designed to deliver pain relief to chronic pain and diabetes patients, which has ...
Yahoo Finance

NeuroMetrix completes 510(k) clearance process for SENSUS device

NeuroMetrix reported that it has received 510(k) clearance from the U.S. Food and Drug Administration for the disposable electrode that is used in conjunction with its SENSUS device. This regulatory ...